US Food and Drug Administration's Directive to Deal With Delayed Confirmatory Trials: Lessons From Pralatrexate and Belinostat for T-Cell Lymphoma
- Edward R.Scheffer Cliff
- , David A. Russler-Germain
- , C. Joseph Ross Daval
- , Aaron S. Kesselheim
Research output: Contribution to journal › Comment/debate
6
Link opens in a new tab
Scopus
citations